Current Neuro-Oncology

Volume 16 Number 2
28 February 2014

Home > Publications > Current Neuro-Oncology > Volume 16, Year 2014 > Number 2, 28 February

Derlin T, Clauditz TS, Bannas P.
Glioblastoma multiforme metastastic to the bone: diagnosis by (18)F-NaF PET/CT.
Clin Nucl Med. 2014 Feb;39(2):188-9∟. doi: 10.1097/RLU.0b013e3182873075∟. PMID: 24300358∟. Case report˰ ˍ

D’Elia A, Maiola V, Manucci M, Pichierri A, Frati A, Giangaspero F, Salvati M.
Extended Daily Schedule of Temozolomide in Recurrent Glioblastoma: Single-Institution Report on a Series of 43 Patients.
J Cancer Ther. 2014 Feb 10, 2014;5(2):155-166∟. doi: 10.4236/jct.2014.52019∟. No PMD. Case report. ˍ

Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea D, Brandes AA, Hilton M, Abrey L, Cloughesy T.
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.
N Engl J Med. 2014 Feb 20;370(8):709-22∟. doi: 10.1056/NEJMoa1308345∟. PMID: 24552318∟. Interventional study. ˍ

Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Stieber VW, Brachman DG, Werner-Wasik M, Tremont-Lukats IW, Sulman EP, Aldape KD, Curran WJ Jr, Mehta MP.
A randomized trial of bevacizumab for newly diagnosed glioblastoma.
N Engl J Med. 2014 Feb 20;370(8):699-708∟. doi: 10.1056/NEJMoa1308573∟. PMID: 24552317∟. Interventional study. ˍ